Lebrikizumab Delivers Clinically Meaningful and Continuous Improvement in Itch-Free Days in Atopic Dermatitis Through One Year

Main Article Content

Gil Yosipovitch
Claudia Zeidler
Christian J. Apfelbacher
Vivian Laquer
Brian S. Kim
Marta Casillas
Evangeline Pierce
Sherry Chen
Meihua Qiao
Helena Agell
James Del Rosso


Lebrikizumab, atopic dermatitis, itch


1. Silverberg JI, et al. N Engl J Med. 2023;388:1080-1091.

2. Okragly AJ, et al. Dermatol Ther (Heidelb). 2023;13:1535-1547.

3. Moyle M, et al. Exp Dermatol. 2019;28:756-768.

4. Blauvelt A, et al. Br J Dermatol. 2023;188:740-748.

5. Yosipovitch G, et al. Br J Dermatol. 2022;186:135-185.

6. Yosipovitch G, et al. Br J Dermatol. 2019;181:761-769.

Similar Articles

1 2 3 > >> 

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 4 5 6 7 > >>